Alibaba’s research arm gets US regulator nod for AI cancer tool

Alibaba’s research arm gets US regulator nod for AI cancer tool

Tech in Asia·2025-04-20 17:00

Alibaba Group’s research arm, Damo Academy, has received “breakthrough device” designation from the US Food and Drug Administration (FDA) for its AI-powered pancreatic cancer detection tool, Damo Panda.

This status allows for an expedited review and approval process.

……

Read full article on Tech in Asia

Technology Health